Dean Capital Investments Management LLC lowered its holdings in Stryker Co. (NYSE:SYK) by 63.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 3,333 shares of the medical technology company’s stock after selling 5,885 shares during the period. Dean Capital Investments Management LLC’s holdings in Stryker were worth $563,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. River Wealth Advisors LLC grew its position in Stryker by 1.1% during the first quarter. River Wealth Advisors LLC now owns 29,300 shares of the medical technology company’s stock valued at $4,715,000 after acquiring an additional 309 shares during the period. Benedict Financial Advisors Inc. grew its position in Stryker by 7.2% during the second quarter. Benedict Financial Advisors Inc. now owns 4,681 shares of the medical technology company’s stock valued at $790,000 after acquiring an additional 313 shares during the period. Janney Montgomery Scott LLC grew its position in Stryker by 1.5% during the second quarter. Janney Montgomery Scott LLC now owns 21,307 shares of the medical technology company’s stock valued at $3,598,000 after acquiring an additional 316 shares during the period. Mogy Joel R Investment Counsel Inc. grew its position in Stryker by 0.4% during the first quarter. Mogy Joel R Investment Counsel Inc. now owns 86,568 shares of the medical technology company’s stock valued at $13,931,000 after acquiring an additional 325 shares during the period. Finally, Altavista Wealth Management Inc. grew its position in Stryker by 1.0% during the first quarter. Altavista Wealth Management Inc. now owns 35,165 shares of the medical technology company’s stock valued at $5,659,000 after acquiring an additional 361 shares during the period. 74.72% of the stock is owned by institutional investors and hedge funds.

Shares of Stryker opened at $165.88 on Friday, according to Marketbeat.com. Stryker Co. has a 1-year low of $137.70 and a 1-year high of $179.84. The company has a quick ratio of 1.15, a current ratio of 1.83 and a debt-to-equity ratio of 0.63. The stock has a market capitalization of $61.78 billion, a PE ratio of 25.56, a P/E/G ratio of 2.34 and a beta of 0.62.

Stryker (NYSE:SYK) last issued its earnings results on Tuesday, July 24th. The medical technology company reported $1.76 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.73 by $0.03. Stryker had a return on equity of 26.93% and a net margin of 8.28%. The company had revenue of $3.32 billion during the quarter, compared to the consensus estimate of $3.31 billion. During the same quarter in the prior year, the business earned $1.53 earnings per share. The company’s revenue was up 10.3% compared to the same quarter last year. research analysts anticipate that Stryker Co. will post 7.25 EPS for the current fiscal year.

A number of equities research analysts have issued reports on SYK shares. Zacks Investment Research raised Stryker from a “hold” rating to a “buy” rating and set a $192.00 price target for the company in a research report on Monday, May 21st. Canaccord Genuity boosted their price target on Stryker from $176.00 to $185.00 and gave the company a “buy” rating in a research report on Friday, April 27th. Stifel Nicolaus boosted their price target on Stryker from $183.00 to $187.00 and gave the company a “buy” rating in a research report on Friday, April 27th. ValuEngine raised Stryker from a “hold” rating to a “buy” rating in a research report on Tuesday, June 26th. Finally, Royal Bank of Canada reaffirmed a “buy” rating and issued a $184.00 target price on shares of Stryker in a research report on Wednesday, July 25th. One analyst has rated the stock with a sell rating, nine have given a hold rating and fifteen have given a buy rating to the stock. Stryker has an average rating of “Buy” and an average price target of $175.90.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices for use in various medical specialties.

Featured Article: How to Invest in Growth Stocks

Want to see what other hedge funds are holding SYK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stryker Co. (NYSE:SYK).

Institutional Ownership by Quarter for Stryker (NYSE:SYK)

Receive News & Ratings for Stryker Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stryker and related companies with MarketBeat.com's FREE daily email newsletter.